Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
about
Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expressionMetastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulatorHeregulin promotes expression and subcellular redistribution of ADP-ribosylation factor 3Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signalingERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells.Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.Tissue polarity-dependent control of mammary epithelial homeostasis and cancer development: an epigenetic perspective.Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter.Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cellsThe Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.Trichostatin A Enhances the Apoptotic Potential of Palladium Nanoparticles in Human Cervical Cancer Cells.Multidrug-resistant breast cancer: current perspectives.Histone H3 phosphorylation, immediate-early gene expression, and the nucleosomal response: a historical perspective.Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells.Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability.Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer.Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3).Mutant p53 gain of function induces HER2 over-expression in cancer cells.
P2860
Q24289242-0485C4C0-EE27-4DD5-86B4-BC73988E9985Q24564251-5C6873C3-15FF-4CFE-B8DD-90F56B90415CQ28215669-1FD05179-EAA9-4C73-A962-730D42CB137FQ28289659-55B8808F-389C-421F-AC70-CB01ACFC1EE7Q30576405-DC834ABA-D6D6-48E1-801B-BCD133D67B55Q33428310-824B743C-3481-4A8F-8E10-01A2E357CD26Q33817720-707BE08D-0C8C-4DF3-BBF2-CCE4FBCFB692Q34184485-F8082A26-E9F5-4F07-8349-17DAA3FCE3B8Q34367908-1DD7FFBF-4845-4E08-BC69-3BD7F5B976F1Q36061535-7E8B38C1-2C0D-4F2E-9DA9-4E0E62D1E89FQ37210234-03DFB9F9-7959-4458-ADC1-7E3D3E3AB7CEQ37593383-6A00364F-8051-4C8E-B887-A2F1BA26881CQ37976424-B56C4320-2930-4FF8-96F3-58F67893EDD7Q39404006-F4E15DD4-7F53-4109-99A9-6A0D22ACC4F2Q40039538-A8FD1053-9169-4BE5-B681-4B2E3845B966Q40407389-1721E4B2-E721-4087-915E-572D1B8555C7Q41382946-CE390FC3-2EF0-4AC1-BD30-67AB893FC99AQ42659391-C3B9468B-2B82-4B25-BA22-CF468289C857Q55455939-F2E361B2-6ADD-4B7A-80D8-E7E9BD084096
P2860
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
@en
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
@nl
type
label
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
@en
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
@nl
prefLabel
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
@en
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
@nl
P2093
P2860
P1433
P1476
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells
@en
P2093
P2860
P356
10.1016/S0014-5793(01)02951-9
P407
P50
P577
2001-10-01T00:00:00Z